BR112012001495B1 - composição de fixação citológica ou histológica e processos para a coloração - Google Patents
composição de fixação citológica ou histológica e processos para a coloração Download PDFInfo
- Publication number
- BR112012001495B1 BR112012001495B1 BR112012001495-1A BR112012001495A BR112012001495B1 BR 112012001495 B1 BR112012001495 B1 BR 112012001495B1 BR 112012001495 A BR112012001495 A BR 112012001495A BR 112012001495 B1 BR112012001495 B1 BR 112012001495B1
- Authority
- BR
- Brazil
- Prior art keywords
- solution
- composition
- preparation
- contact
- staining
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 59
- 238000010186 staining Methods 0.000 title claims abstract description 50
- 238000000034 method Methods 0.000 title claims abstract description 41
- 230000002380 cytological effect Effects 0.000 title abstract description 5
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims abstract description 74
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims abstract description 59
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 57
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 38
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 32
- 229910001868 water Inorganic materials 0.000 claims abstract description 30
- 239000011780 sodium chloride Substances 0.000 claims abstract description 20
- 239000000243 solution Substances 0.000 claims description 48
- 210000004027 cell Anatomy 0.000 claims description 40
- 239000008280 blood Substances 0.000 claims description 25
- 210000004369 blood Anatomy 0.000 claims description 25
- 238000002360 preparation method Methods 0.000 claims description 24
- 229960000907 methylthioninium chloride Drugs 0.000 claims description 15
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical group C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 claims description 12
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 12
- 239000001045 blue dye Substances 0.000 claims description 11
- 238000003756 stirring Methods 0.000 claims description 11
- 238000010191 image analysis Methods 0.000 claims description 10
- 239000012128 staining reagent Substances 0.000 claims description 10
- 239000001044 red dye Substances 0.000 claims description 9
- 238000004458 analytical method Methods 0.000 claims description 8
- 239000007853 buffer solution Substances 0.000 claims description 8
- 230000000295 complement effect Effects 0.000 claims description 8
- 239000000975 dye Substances 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 238000007447 staining method Methods 0.000 claims description 7
- 238000004040 coloring Methods 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- AGIJRRREJXSQJR-UHFFFAOYSA-N 2h-thiazine Chemical group N1SC=CC=C1 AGIJRRREJXSQJR-UHFFFAOYSA-N 0.000 claims description 4
- 210000003850 cellular structure Anatomy 0.000 claims description 4
- 150000004897 thiazines Chemical class 0.000 claims description 4
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical group [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 claims description 2
- IINNWAYUJNWZRM-UHFFFAOYSA-L erythrosin B Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 IINNWAYUJNWZRM-UHFFFAOYSA-L 0.000 claims description 2
- 229940011411 erythrosine Drugs 0.000 claims description 2
- 235000012732 erythrosine Nutrition 0.000 claims description 2
- 239000004174 erythrosine Substances 0.000 claims description 2
- 239000012487 rinsing solution Substances 0.000 claims 3
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 claims 1
- 239000000834 fixative Substances 0.000 abstract description 18
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- 238000005406 washing Methods 0.000 description 7
- 230000001413 cellular effect Effects 0.000 description 6
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 6
- 229910000397 disodium phosphate Inorganic materials 0.000 description 6
- 235000019800 disodium phosphate Nutrition 0.000 description 6
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 6
- 235000019796 monopotassium phosphate Nutrition 0.000 description 6
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 6
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 6
- 239000001488 sodium phosphate Substances 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 231100000331 toxic Toxicity 0.000 description 5
- 230000002588 toxic effect Effects 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 239000004599 antimicrobial Substances 0.000 description 4
- 239000003086 colorant Substances 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 238000007605 air drying Methods 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- NALREUIWICQLPS-UHFFFAOYSA-N 7-imino-n,n-dimethylphenothiazin-3-amine;hydrochloride Chemical compound [Cl-].C1=C(N)C=C2SC3=CC(=[N+](C)C)C=CC3=NC2=C1 NALREUIWICQLPS-UHFFFAOYSA-N 0.000 description 2
- 238000002738 Giemsa staining Methods 0.000 description 2
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- DNDJEIWCTMMZBX-UHFFFAOYSA-N n,n-dimethyl-7-methyliminophenothiazin-3-amine;hydrochloride Chemical compound [Cl-].C1=CC(=[N+](C)C)C=C2SC3=CC(NC)=CC=C3N=C21 DNDJEIWCTMMZBX-UHFFFAOYSA-N 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 208000035404 Autolysis Diseases 0.000 description 1
- 206010057248 Cell death Diseases 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- PPWHTZKZQNXVAE-UHFFFAOYSA-N Tetracaine hydrochloride Chemical compound Cl.CCCCNC1=CC=C(C(=O)OCCN(C)C)C=C1 PPWHTZKZQNXVAE-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000008366 buffered solution Substances 0.000 description 1
- 230000005859 cell recognition Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000001744 histochemical effect Effects 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 229910052762 osmium Inorganic materials 0.000 description 1
- SYQBFIAQOQZEGI-UHFFFAOYSA-N osmium atom Chemical compound [Os] SYQBFIAQOQZEGI-UHFFFAOYSA-N 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000028043 self proteolysis Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Sampling And Sample Adjustment (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0955127 | 2009-07-22 | ||
| FR0955127A FR2948456B1 (fr) | 2009-07-22 | 2009-07-22 | Composition de fixation cytologique ou histologique et procedes de coloration |
| PCT/FR2010/051540 WO2011010064A1 (fr) | 2009-07-22 | 2010-07-21 | Composition de fixation cytologique ou histologique et procedes de coloration |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112012001495A2 BR112012001495A2 (pt) | 2020-09-24 |
| BR112012001495B1 true BR112012001495B1 (pt) | 2021-07-06 |
Family
ID=41722889
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112012001495-1A BR112012001495B1 (pt) | 2009-07-22 | 2010-07-21 | composição de fixação citológica ou histológica e processos para a coloração |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US9366604B2 (enExample) |
| EP (1) | EP2457079B1 (enExample) |
| JP (1) | JP5704466B2 (enExample) |
| BR (1) | BR112012001495B1 (enExample) |
| ES (1) | ES2555219T3 (enExample) |
| FR (1) | FR2948456B1 (enExample) |
| HU (1) | HUE028309T2 (enExample) |
| IN (1) | IN2012DN01386A (enExample) |
| RU (1) | RU2536502C2 (enExample) |
| WO (1) | WO2011010064A1 (enExample) |
| ZA (1) | ZA201201238B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103874913B (zh) | 2011-06-17 | 2017-04-26 | 罗氏血液诊断股份有限公司 | 用于生物样品的组织加工的溶液 |
| AU2016246542B2 (en) | 2015-04-06 | 2021-08-26 | Nanocytomics, LLC | Automated specimen deposition systems and associated methods |
| RU2630983C1 (ru) * | 2016-04-06 | 2017-09-15 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Кубанский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО КубГМУ Минздрава России) | Фиксатор проб для цитологических исследований |
| CN112781961A (zh) * | 2019-11-07 | 2021-05-11 | 北京望升伟业科技发展有限公司 | 一种细胞快速染色液及其应用 |
| EP4577820A1 (en) * | 2022-11-07 | 2025-07-02 | Bio-Gram Hematology GmbH | Staining reagent |
| DE102022129378B3 (de) | 2022-11-07 | 2024-05-08 | Bio-Gram Diagnostics GmbH | Färbereagenz |
| CN115855607A (zh) * | 2022-12-13 | 2023-03-28 | 湖南友哲科技有限公司 | 一种尿有形成分分析仪用染色液及其制备方法与使用方法 |
| DE102024105392A1 (de) * | 2024-02-27 | 2025-08-28 | Bio-Gram Hematology GmbH | Färbereagenz |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5260048A (en) * | 1991-05-08 | 1993-11-09 | Streck Laboratories, Inc. | Tissue fixative solution and method |
| WO1994007532A1 (en) * | 1992-09-10 | 1994-04-14 | Streck Laboratories, Inc. | Method and composition for preserving antigens and process for utilizing cytological material produced by same |
| RU2178565C2 (ru) * | 1996-01-16 | 2002-01-20 | Зила Инк. | Способы и композиции для обнаружения in vivo оральных злокачественных опухолей и предраковых состояний |
| DE10034647C1 (de) * | 2000-07-14 | 2002-04-04 | 3M Espe Ag | Verfahren zur Durchführung einer Speichelanalyse |
| JP2003061511A (ja) * | 2001-08-30 | 2003-03-04 | Sumitomo Pharmaceut Co Ltd | 炎症性疾患治療剤の新規評価方法 |
| FR2854239B1 (fr) * | 2003-04-23 | 2006-03-10 | Reactifs Ral | Procede de preparation d'un reactif de coloration de cellules et reactif obtenu |
| EP1804045B1 (de) * | 2005-12-30 | 2014-03-12 | QIAGEN GmbH | Ein Verfahren und ein Kit zur Behandlung einer biologischen Probe |
| WO2007089641A2 (en) * | 2006-01-26 | 2007-08-09 | The University Of Texas | Process and apparatus for imaging |
| FR2907220B1 (fr) * | 2006-10-11 | 2009-01-16 | Reactifs Ral Sa | Procede de coloration de cellules |
| EP2027922A1 (de) * | 2007-08-02 | 2009-02-25 | Qiagen GmbH | Verfahren und Vorrichtung für das Fixieren/Stabilisieren einer Probe |
-
2009
- 2009-07-22 FR FR0955127A patent/FR2948456B1/fr active Active
-
2010
- 2010-07-21 HU HUE10752066A patent/HUE028309T2/en unknown
- 2010-07-21 IN IN1386DEN2012 patent/IN2012DN01386A/en unknown
- 2010-07-21 WO PCT/FR2010/051540 patent/WO2011010064A1/fr not_active Ceased
- 2010-07-21 BR BR112012001495-1A patent/BR112012001495B1/pt not_active IP Right Cessation
- 2010-07-21 US US13/384,845 patent/US9366604B2/en active Active
- 2010-07-21 RU RU2012106300/05A patent/RU2536502C2/ru active
- 2010-07-21 JP JP2012521086A patent/JP5704466B2/ja active Active
- 2010-07-21 EP EP10752066.0A patent/EP2457079B1/fr active Active
- 2010-07-21 ES ES10752066.0T patent/ES2555219T3/es active Active
-
2012
- 2012-02-20 ZA ZA2012/01238A patent/ZA201201238B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2012106300A (ru) | 2013-08-27 |
| FR2948456A1 (fr) | 2011-01-28 |
| RU2536502C2 (ru) | 2014-12-27 |
| US9366604B2 (en) | 2016-06-14 |
| ES2555219T3 (es) | 2015-12-29 |
| US20120122151A1 (en) | 2012-05-17 |
| JP2012533745A (ja) | 2012-12-27 |
| FR2948456B1 (fr) | 2011-09-30 |
| WO2011010064A1 (fr) | 2011-01-27 |
| EP2457079A1 (fr) | 2012-05-30 |
| HUE028309T2 (en) | 2016-12-28 |
| JP5704466B2 (ja) | 2015-04-22 |
| EP2457079B1 (fr) | 2015-09-09 |
| BR112012001495A2 (pt) | 2020-09-24 |
| IN2012DN01386A (enExample) | 2015-06-05 |
| ZA201201238B (en) | 2012-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112012001495B1 (pt) | composição de fixação citológica ou histológica e processos para a coloração | |
| US8158381B2 (en) | Methods for integrated tissue processing and staining | |
| Al-Sabawy et al. | Standard techniques for formalin-fixed paraffin-embedded tissue: a pathologist's perspective. | |
| Layton et al. | Fixation of tissues | |
| CN104155160A (zh) | 一种不含苯的组织脱蜡透明剂 | |
| JP2014505248A (ja) | ヘマトキシリン染色法 | |
| ES2688322T3 (es) | Composición, uso de la composición y método para el procesamiento de muestras histológicas y citológicas, post mortem | |
| CN103827654A (zh) | 用于制备进行检查的细胞学样品的系统和试剂盒 | |
| CN111811909A (zh) | 一种组织自发荧光淬灭剂的制备及应用 | |
| Ajileye et al. | Fixation and fixatives in histopathology: a review | |
| Hasan et al. | A better and copacetic protocol for histopathological slide preparation using H&E stain: A review | |
| Estable et al. | Technical procedures for the study of the nucleolonema | |
| RU2202776C2 (ru) | Способ окраски гистологических препаратов | |
| Okajima | On the elective staining of the erythrocyte | |
| RU2593343C1 (ru) | Способ окраски гистологических срезов при диагностике трихинеллеза | |
| JP3875916B2 (ja) | 尿沈渣検査用試薬及び尿沈渣の検査方法 | |
| PT106082A (pt) | Composição fixadora para citologia, método de fixação de células e suas aplicações | |
| ES2322692T3 (es) | Tincion de plata con gelatina no gelificante. | |
| Kashyap | Comparison of three alum Hematoxylin–Harris, Mayer’s, Ehrlich Hematoxylin using different tissues–a study of 60 cases | |
| JP2016211929A (ja) | 膠原線維染色法の染色剤及び膠原線維染色法 | |
| Bhairahawa | Comparison of Three Alum Hematoxylin–Harris, Mayer’s, Ehrlich Hematoxylin Using Different Tissues–A Study of 60 Cases | |
| BR102021026290A2 (pt) | Processo de preparo e formulação para contagem total e diferencial de leucócitos em meio líquido | |
| IT202000014863A1 (it) | Kit per la preparazione di citoinclusi | |
| Hjort et al. | New rapid methods for tissue diagnosis | |
| De Tomasi | Laboratory Hints from the Literature |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B25F | Entry of change of name and/or headquarter and transfer of application, patent and certif. of addition of invention: change of name on requirement |
Owner name: REACTIFS RAL (FR) Free format text: A FIM DE ATENDER A ALTERACAO DE NOME REQUERIDA ATRAVES DA PETICAO NO 18120016607, DE 11/05/2012, E NECESSARIO APRESENTAR O DOCUMENTO NOTARIZADO E A TRADUCAO JURAMENTADA, ALEM DA GUIA DE CUMPRIMENTO DE EXIGENCIA. |
|
| B25E | Requested change of name of applicant rejected |
Owner name: REACTIFS RAL (FR) Free format text: INDEFERIDO O PEDIDO DE ALTERACAO DE NOME CONTIDO NA PETICAO 18120016607 DE 11/05/2012, POR AUSENCIA DE CUMPRIMENTO DA EXIGENCIA PUBLICADA NA RPI NO 2601, DE 10/11/2020. |
|
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 21/07/2010, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO. |
|
| B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 14A ANUIDADE. |
|
| B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2784 DE 14-05-2024 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |